Abed Agbarya
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
- Lung Cancer Research Studies
-
- Complementary and Alternative Medicine Studies
Papers in
- Oncology 43
- Cancer Immunotherapy and Biomarkers 12
- Lung Cancer Research Studies 10
- COVID-19 and healthcare impacts 9
- Colorectal Cancer Treatments and Studies 6
-
- Lung Cancer Treatments and Mutations 28
- Lung Cancer Diagnosis and Treatment 12
- Co-authors
- Nicola J. Nasser (5 shared papers)Hagit Padova (2 shared papers)Barliz Waissengrin (2 shared papers)Ido Wolf (5 shared papers)Miguel Gorenberg (4 shared papers)Elizabeth Dudnik (8 shared papers)Eran Ben‐Arye (8 shared papers)Mira Wollner (5 shared papers)
- Journals
- Cancers (6 papers)Journal of Clinical Medicine (6 papers)Journal of Thoracic Oncology (4 papers)Biomedicines (4 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- IsraelUnited StatesGreece
In The Last Decade
Abed Agbarya
63 papers receiving 887 citations
Peers
Comparison fields: 5 of 87
- Oncology 456
- Complementary and alternative medicine 99
- Pulmonary and Respiratory Medicine 318
- Internal Medicine 33
- Infectious Diseases 137
Countries citing papers authored by Abed Agbarya
This map shows the geographic impact of Abed Agbarya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abed Agbarya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abed Agbarya more than expected).
Fields of papers citing papers by Abed Agbarya
This network shows the impact of papers produced by Abed Agbarya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abed Agbarya. The network helps show where Abed Agbarya may publish in the future.
Co-authors
The 25 scholars most cited alongside Abed Agbarya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 155 | |
| 2 | 2021 | 117 | |
| 3 | 2020 | 63 | |
| 4 | 2012 | 55 | |
| 5 | 2020 | 52 | |
| 6 | 2014 | 50 | |
| 7 | 2021 | 33 | |
| 8 | 2021 | 29 | |
| 9 | 2022 | 25 | |
| 10 | 2014 | 22 | |
| 11 | 2014 | 16 | |
| 12 | 2022 | 16 | |
| 13 | 2014 | 15 | |
| 14 | 2020 | 14 | |
| 15 | 2024 | 12 | |
| 16 | 2022 | 12 | |
| 17 | 2021 | 12 | |
| 18 | 2016 | 11 | |
| 19 | 2017 | 11 | |
| 20 | 2021 | 11 |
About Abed Agbarya
Abed Agbarya is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Surgery, having authored 76 papers that have together received 896 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (28 papers), Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Research Studies (10 papers), COVID-19 and healthcare impacts (9 papers), Cancer Genomics and Diagnostics (7 papers), Complementary and Alternative Medicine Studies (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Oncology (456 citations), Complementary and alternative medicine (99 citations), Pulmonary and Respiratory Medicine (318 citations), Internal Medicine (33 citations) and Infectious Diseases (137 citations). Abed Agbarya has collaborated with scholars based in Israel, United States and Greece. Frequent co-authors include Nicola J. Nasser, Hagit Padova, Barliz Waissengrin, Ido Wolf, Miguel Gorenberg, Elizabeth Dudnik, Eran Ben‐Arye, Mira Wollner, Walid Shalata and Gil Bar‐Sela. Their work appears in journals such as Cancers, Journal of Clinical Medicine, Journal of Thoracic Oncology, Biomedicines and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.